Willingness to receive COVID-19 vaccine booster among general population of India: an online cross sectional study
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20222224Keywords:
COVID-19 vaccine, booster, Willingness, Hesitancy, General population, IndiaAbstract
Background: Booster dose for COVID-19 vaccine is being administered by many countries and has recently been started by India for special groups. Hence, it is important to understand the willingness of people to receive the booster dose and factors associated with it.
Methods: The present study was a community based Online Cross-sectional study done by using internet based social media applications for a period of 10 days from 6th January to 15th January 2022.
Results: Out of which 70.6% were willing to receive the booster, 7.6% were not willing and 21.8% were undecided. Reasons for willingness were the belief to boost immunity (61.3%), protection from new variants (45.9%), reduced severity of infection (43.2%) or hospitalization (42.8%).
Conclusions: The main reasons for unwillingness were, being unsure about its benefits (59.7%), fear of side effects (26.5%) and no trust on vaccine for protection against new variants (26.5%). People with higher education, history of COVID-19 infection or hospitalization among family and those perceiving more severe infections by new variants were more willing to get the booster.
Metrics
References
Wong LP, Alias H, Danaee M. COVID-19 vaccination intention and vaccine characteristics influencing vaccination acceptance: a global survey of 17 countries. Infectious diseases of poverty. 2021; 10(1):1-4.
Pawlowski C, Lenehan P, Puranik A. FDA-authorized COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system. MedRxiv. 2021.
Dagan N, Barda N, Kepten E. BNT162b2 mRNA COVID-19 vaccine in a nationwide mass vaccination setting. N Engl J Med. 2021;384(15):1412-23.
Kim JH, Marks F, Clemens JD. Looking beyond COVID-19 vaccine phase 3 trials. Nat Med. 2021; 27(2):205-11.
Mizrahi B, Lotan R, Kalkstein N. Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine. Nat Commun. 2021;12(1):1-5.
Nanduri S, Pilishvili T, Derado G. Effectiveness of Pfizer-BioNTech and Moderna vaccines in preventing SARS-CoV-2 infection among nursing home residents before and during widespread circulation of the SARS-CoV-2-B.1.617.2 (Delta) variant-National Healthcare Safety Network 2021. Morbid Mortal Weekly Rep. 2021;70(34):1163.
Rosenberg ES, Holtgrave DR, Dorabawila V. New COVID-19 cases and hospitalizations among adults, by vaccination status-New York, 2021. Morbid Mortal Weekly Rep. 2021;70(37):1306.
Yadete T, Batra K, Netski DM, Antonio S, Patros MJ, Bester JC. Assessing acceptability of COVID-19 vaccine booster dose among adult Americans: A cross-sectional study. Vaccines. 2021;9(12):1424.
Paul E, Steptoe A, Fancourt D. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. Lancet Reg Health-Eur. 2021;1:100012.
Kishore J, Venkatesh U, Ghai G, Kumar P. Perception and attitude towards COVID-19 vaccination: A preliminary online survey from India. J Family Med Prim Care. 2021;10(8):3116-21.
Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines. 2021;9(2):160.
Rzymski P, Poniedziałek B, Fal A. Willingness to receive the booster COVID-19 vaccine dose in Poland. Vaccines. 2021;9(11):1286.
Pal S, Shekhar R, Kottewar S, Upadhyay S. COVID-19 vaccine hesitancy and attitude toward booster doses among US healthcare workers. Vaccines. 2021; 9(11): 1358.
Lai X, Zhu H, Wang J. Public perceptions and acceptance of covid-19 booster vaccination in China: a cross-sectional study. Vaccines. 2021;9(12):1461.
Vogel L, Duong D. What’s the evidence for COVID-19 booster shots?. Can Med Assoc J. 2021;193(35): E1400.
Alexander CA, Wang L, Shah V. Vaccine hesitancy, vaccine acceptance, and recommendations about the COVID-19 vaccines. J Med Res Health Sci. 2021; 4(12):1599-609.
Al Janabi T, Pino M. Predictors for actual COVID-19 vaccine uptake and intended booster dosage among medical students of an osteopathic medical school in New York. Epidemiol. 2021;2(4):553-63.
Ransing R, Kukreti P, Raghuveer P. A brief psycho-social intervention for COVID-19 vaccine hesitancy among perinatal women in low-and middle-income countries: Need of the hour. Asian J Psychiatr. 2022; 67:102929.
Steens A, Stefanoff P, Daae A, Vestrheim DF, Bergsaker MA. High overall confidence in childhood vaccination in Norway, slightly lower among the unemployed and those with a lower level of education. Vaccine. 2020 ;38(29):4536-41.
